AstraZeneca has recently completed a significant clinical study titled ‘A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and ...

Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study ...

Asthma affects approximately 25 million Americans, including 5.1 million children, according to the Asthma and Allergy Foundation of America. While many experience mild symptoms that respond well to ...

After positive results in phase 3 trials, a GSK experimental therapy could be the first ultra-long-acting biologic approved for severe asthma. The drug candidate, depemokimab, was measured in severe ...

If you are wheezing, coughing, or having extreme shortness of breath, you may be having an asthma attack.

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to ...

The study uncovers high reliance on oral corticosteroids for asthma in Italy, pointing to gaps in guideline adherence and the ...

Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

A recent insurance policy change in five states may mean patients with severe asthma could face additional delays, including in New Mexico. (Getty Images) A recent policy change by the largest private ...